Benjamin E. Draper
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
39
Citations
575
Est. group size
—
Recurring co-author estimate
Active years
61
Publishing since 1966
Benjamin E. Draper studies gene therapy tools, focusing on adeno-associated virus (AAV) vectors, which are engineered viruses used to deliver therapeutic genes into cells. His work combines analytical techniques such as mass spectrometry and electrical mobility measurements to characterize these vectors, and explores using CRISPR gene-editing technology delivered via AAV. He examines how vector properties like genome size affect production, purification, and stability.
Publication activity has grown over the last decade, rising from occasional papers in the late 2010s to a peak of around 7-8 papers per year in 2024-2025.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- High resolution ES-DMA quantifies AAV capsid DNA content by electrical mobility to mass correlation
Gene Therapy · 2026
- Toward an all-in-one recombinant adeno-associated virus vector for functionally ablating the prion gene using CRISPR-Cas technology
PLoS ONE · 2025
- Recombinant AAV genome size effect on viral vector production, purification, and thermostability
Molecular Therapy — Methods & Clinical Development · 2024
- Analytical Chemistry×10
- Molecular Therapy — Methods & Clinical Development×7
- Journal of the American Society for Mass Spectrometry×3
- Frontiers in Bioengineering and Biotechnology×2
- bioRxiv (Cold Spring Harbor Laboratory)×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile